Credit: Modupe Idowu, MD, professor and medical director of the Adult Sickle Cell Comprehensive Center at UTHealth Houston, is enrolling patients in the Phase III clinical drug trial. (Photo by UTHealth Houston/ Nathan Jeter)
Modupe Idowu, MD, professor and medical director of the Adult Sickle Cell Comprehensive Center at UTHealth Houston, is enrolling patients in the Phase III clinical drug trial. (Photo by UTHealth Houston/ Nathan Jeter)